Patents Assigned to Sandoz Pharmaceuticals Corporation
  • Human antibodies against varicella-zoster virus
    Patent number: 5506132
    Abstract: The invention provides human monoclonal antibodies specific for the glycoprotein II subunit of Varicella-zoster virus. Preferred antibodies exhibit strong complement-independent neutralizing activity, antibody dependent cellular cytotoxicity, and cross-reactivity with multiple strains of Varicella-zoster virus.
    Type: Grant
    Filed: March 24, 1994
    Date of Patent: April 9, 1996
    Assignee: Sandoz Pharmaceuticals Corporation
    Inventors: Philip Lake, Lars Ostberg